Biotech investors waiting for partnership announcements
Shares of PharmaGap (TSX: V.GAP) rallied 31% to 19 cents on Wednesday.
The company is a drug developer working on a cancer treatment. It has completed safety trials in some animal models.
Post Metadata
Views
646 views
Date
January 27th, 2010
Author
Smallcapcenter
